Resistance training prevents muscle loss in GLP-1 drug users, study shows
A new study found that participants taking GLP-1 receptor agonists who also performed resistance exercise maintained lean muscle mass, addressing a key clinical concern about semaglutide-class obesity treatments.
- Study group doing resistance exercise lost negligible lean mass on GLP-1 therapy
- Exercise-plus-drug participants maintained or slightly improved strength markers
- Researchers suggest findings support pairing structured exercise protocols with GLP-1 prescriptions